Erratum to "Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: The RELIEF trial" [J. Clin. Virol. 43 (October (2)) (2008) 190-195] (DOI:10.1016/j.jcv.2008.06.004);Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: The RELIEF trial

Journal of Clinical Virology

Volumn 43, Issue 2, 2008, Pages 190-195

  Bartlett, Brenda L ^a   Tyring, Stephen K ^a   Fife, Kenneth ^b   Gnann Jr , John W ^c   Hadala, Joseph T ^d   Kianifard, Farid ^d   Berber, Erhan ^d  

^a UNIVERSITY OF TEXAS   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Famciclovir; Genital herpes; Herpes simplex virus; Recurrent

Indexed keywords

FAMCICLOVIR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; UNSPECIFIED SIDE EFFECT;

EID: 50849125096     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.11.012     Document Type: Erratum

References (27)

1. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 55 No. RR-11 (2006) 16-21
2. Benedetti J., Corey L., and Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 121 11 (1994) 847-854
3. Engelberg R., Carrell D., Krantz E., Corey L., and Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transmit Dis 30 2 (2003) 174-177
4. Corey L., and Holmes K.K. Genital herpes simplex virus infection: current concepts in diagnosis, therapy and prevention. Ann Intern Med 98 6 (1983) 973-983
5. Wald A. New therapies and prevention strategies for genital herpes. Clin Infect Dis 28 Suppl. 1 (1999) S4-S13
6. Aoki F.Y., Tyring S., Diaz-Mitoma F., Gross G., Gao J., and Hamed K. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 42 1 (2006) 8-13 [Erratum in: Clin Infect Dis 2006;42(4):58]
7. Gupta R., and Wald A. Genital herpes: antiviral therapy for symptom relief and prevention of transmission. Expert Opin Pharmacother 7 6 (2006) 665-675
8. Sacks S.L., Aoki F.Y., Martel A.Y., Shafran S.D., and Lassonde M. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial. Clin Infect Dis 41 October (15) (2005) 1097-1104
9. Sacks S.L., Aoki F.Y., Diaz-Mitoma F., Sellors J., and Shafran S.D. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA 276 (1996) 44-49
10. Chosidow O., Drouault Y., Leconte-Veyriac F., Aymard M., Ortonne J.P., Pouget F., et al. Famciclovir vs. acyclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-group, randomized, double-blind clinical trial. Br J Dermatol 144 4 (2001) 818-824
11. Tyring S.K., Diaz-Mitoma F., Shafran S.D., Locke L.A., Sacks S.L., and Young C.L. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials. J Cutan Med Surg 7 6 (2003) 449-454
12. Diaz-Mitoma F., Sibbald R.G., Shafran S.D., Boon R., and Saltzman R.L. Oral famciclovir for the suppression of recurrent genital herpes. A randomized controlled trial. JAMA 280 (1998) 887-892
13. Mertz G.J., Loveless M.O., Levin M.J., Kraus S.J., Fowler S.L., Goade D., et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med 157 3 (1997) 343-349
14. Famciclovir complete prescribing information. Accessed at: http://www.pharma.us.novartis.com/product/pi/pdf/Famvir.pdf on 27 November 2007.
15. Doward L.C., McKenna S.P., Kohlmann T., Niero M., Patrick D., Spencer B., et al. The international development of the RGHQoL: a quality of life measure for recurrent genital herpes. Qual Life Res 7 2 (1998) 143-153
16. Collett D. Modelling survival data in medical research. 2nd ed. (2003), Chapman & Hall/CRC, Boca Raton, FL
17. Stokes M.E., Davis C.S., and Koch G.G. Categorical data analysis using the sas system. 2nd ed. (2000), SAS Institute, Inc., Cary, NC
18. Freedman L.S. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1 (1982) 121-129
19. Brown Z.A., Kern E.R., Spruance S.L., and Overall J.C. Clinical and virologic course of herpes simplex genitalis. West J Med 130 (1979) 414-421
20. Reichman R.C., Badger G.J., Mertz G.J., Corey L., Richman D.D., Connor J.D., et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA 251 (1984) 2103-2107
21. Wald A., Carrell D., Remington M., Kexel E., Zeh J., and Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 34 (2002) 944-948
22. Alexander L., and Naisbett B. Patient and physician partnerships in managing genital herpes. J Infect Dis 186 Suppl. 1 (2002) S57-S65
23. Patel R., Boselli F., Cairo I., Barnett G., Price M., and Wulf H.C. Patients' perspectives on the burden or recurrent genital herpes. Int J STD AIDS 12 (2001) 640-645
24. Romanowski B, The Valtrex Study HS230017 Group, Marina RB, Roberts JN. Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study. Sex Transm Dis 2003;30(3):226-31.
25. Fife K.H., Almekinder J., and Ofner S. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir. Sex Transm Dis 34 5 (2007) 297-301
26. Benedetti J.K., Zeh J., and Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 131 (1999) 14-20
27. Corey L. Challenges in genital herpes simplex virus management. J Infect Dis 186 Suppl. 1 (2002) S29-S33